Avalon GloboCare (ALBT) Director Felix Lourdes Receives 100,000-Share Award

What Happened
Felix Lourdes, a director of Avalon GloboCare Corp. (ALBT), was granted a derivative award covering 100,000 shares on June 29, 2026. The award shows an acquisition price of $0.00 (derivative transaction code A = Award/Grant). A footnote states 100% of the shares subject to the option/award vested in full on the grant date.

Key Details

• Transaction date: 2026-06-29 (Grant/Award, code A)
• Price: $0.00 per share; total reported acquisition value $0 (derivative instrument)
• Vesting: 100% vested on the grant date (per footnote)
• Shares owned after transaction: Not specified in the provided filing excerpt
• Filing date: 2026-07-13 — appears to be late (Form 4s are normally required within two business days of the transaction)
• Filing accession: 0001213900-26-077588

Context
This was a derivative award (options or similar equity-linked grant) rather than an open-market purchase or sale. Because the award vests immediately and shows $0 cost, the insider obtained the right to 100,000 shares without an out-of-pocket exercise payment per the filing. The late filing may be noteworthy to investors tracking timely insider disclosures; otherwise, awards to directors are common corporate compensation events and do not by themselves indicate a buy or sell sentiment.